MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$155,203K
(25.39%↑ Y/Y)
Income tax benefit
(expense)
-$15K
(-129.41%↓ Y/Y)
Other income
(expense), net
$29,459K
(242.22%↑ Y/Y)
Interest income
$24,885K
(16.77%↑ Y/Y)
Loss before income
tax expense
-$155,218K
(25.36%↑ Y/Y)
Total other income
(expense)
$54,344K
(8972.45%↑ Y/Y)
Loss from operations
-$209,562K
(-0.48%↓ Y/Y)
Total operating
expenses
$209,562K
(0.48%↑ Y/Y)
Gain on sale of
in-process research and...
$10,000K
Research and development
$171,653K
(5.44%↑ Y/Y)
General and
administrative
$47,909K
(4.66%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Spyre Therapeutics, Inc. (SYRE)
Spyre Therapeutics, Inc. (SYRE)